Show simple item record

Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions

dc.contributor.authorAhn, Hyewon*
dc.date.accessioned2021-02-11T22:19:55Z
dc.date.available2021-02-11T22:19:55Z
dc.date.issued2011*
dc.date.submitted2018-11-05 12:58:39*
dc.identifier29433*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/55773
dc.description.abstractThe thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions.*
dc.languageEnglish*
dc.relation.ispartofseriesMunich Intellectual Property Law Center - MIPLC*
dc.subjectK1-7720*
dc.subject.classificationbic Book Industry Communication::L Lawen_US
dc.subject.otherMarkenrecht*
dc.subject.otherUrheberrecht / Gewerblicher Rechtsschutz und Medienrecht*
dc.subject.otherGewerblicher Rechtsschutz*
dc.titlePatentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions*
dc.typebook
oapen.identifier.doihttp://dx.doi.org/10.5771/9783845232188*
oapen.relation.isPublishedBy20c8b06d-3b2b-4af2-acda-fbcfdfea5744*
oapen.relation.isbn9783845232188*
oapen.volume12*
oapen.edition1*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/